Metabolic Dysfunction–Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction-Reference-Cited by-同舟云学术

Metabolic Dysfunction–Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction

Published:2024-07 Issue:2 Volume:167 Page:357-367.e9
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

van Kleef Laurens A.,Francque Sven M.,Prieto-Ortiz Jhon E.,Sonneveld Milan J.,Sanchez-Luque Carlos B.,Prieto-Ortiz Robin G.,Kwanten Wilhelmus J.,Vonghia Luisa,Verrijken An,De Block Christophe,Gadi Zouhir,Janssen Harry L.A.,de Knegt Robert J.,Brouwer Willem Pieter

Publisher

Elsevier BV

Reference38 articles.

1. 2019 global NAFLD prevalence: a systematic review and meta-analysis;Le;Clin Gastroenterol Hepatol,2022

2. Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States;Younossi;Clin Gastroenterol Hepatol,2021

3. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update;J Hepatol,2021

4. Clinical care pathway for the risk stratification and management of patients with nonalcoholic fatty liver disease;Kanwal;Gastroenterology,2021

5. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease;Rinella;Hepatology,2023

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

2. A turning point in hepatology? EASL reflects on the first approved drug for MASH;Journal of Hepatology;2024-08

3. New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?;Journal of Personalized Medicine;2024-07-29

4. Baseline and Dynamic MAF-5 Score to Predict Liver Fibrosis and Liver-Related Events in General Population With MASLD;Clinical Gastroenterology and Hepatology;2024-07

5. EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD);Obesity Facts;2024